UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 390

Sortiert nach

Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2017-10, Vol.15 (10), p.2076-2079

2017

Link zum Volltext

Verfügbarkeit prüfen

Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai‐VTE study

BJOG : an international journal of obstetrics and gynaecology, 2018-11, Vol.125 (12), p.1581-1589

2018

Link zum Volltext

Verfügbarkeit prüfen

Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?

Annals of the Rheumatic Diseases, 2008-03, Vol.67 (3), p.283-287

2008

Link zum Volltext

Verfügbarkeit prüfen

Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis

Vascular health and risk management, 2022-01, Vol.18, p.793-807

2022

Link zum Volltext

Verfügbarkeit prüfen

Oral contraception and menstrual bleeding during treatment of venous thromboembolism: Expert opinion versus current practice: Combined results of a systematic review, expert panel opinion and an international survey

Thrombosis research, 2017-05, Vol.153, p.101-107

2017

Link zum Volltext

Verfügbarkeit prüfen

What are the special features of treatment in the anti-phospho-lipid syndrome?

Revue des maladies respiratoires, 2021-04, Vol.38 Suppl 1, p.e153

2021

Link zum Volltext

Verfügbarkeit prüfen

Net clinical benefit of hospitalization versus outpatient management of patients with acute pulmonary embolism

Journal of thrombosis and haemostasis, 2017-04, Vol.15 (4), p.685-694

2017

Link zum Volltext

Verfügbarkeit prüfen

Antipsychotic drugs and the risk of recurrent venous thromboembolism: A prospective cohort study

European journal of internal medicine, 2018-06, Vol.52, p.22-27

2018

Link zum Volltext

Verfügbarkeit prüfen

Evaluating efficacy and safety of oral anticoagulation in adult patients with atrial fibrillation and cancer: A systemic review and meta-analysis

Thrombosis update, 2023-08, Vol.12, p.100144, Article 100144

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome

Annals of the rheumatic diseases, 2008-02, Vol.67 (2), p.278-279

2008

Link zum Volltext

Verfügbarkeit prüfen

The risk of venous thromboembolism in renal cell carcinoma patients with residual tumor thrombus

Journal of thrombosis and haemostasis, 2014-06, Vol.12 (6), p.855-859

2014

Link zum Volltext

Verfügbarkeit prüfen

Protein S Heerlen mutation heterozygosity is associated with venous thrombosis risk

Scientific reports, 2017-04, Vol.7 (1), p.45507-45507, Article 45507

2017

Link zum Volltext

Verfügbarkeit prüfen

Oral contraception and menstrual bleeding during treatment of venous thromboembolism: Expert opinion versus current practice

Thrombosis research, 2017-05, Vol.153, p.101-107

2017

Link zum Volltext

Verfügbarkeit prüfen

Venous thromboembolism in cancer patients: a call for more awareness

Current oncology (Toronto), 2014-08, Vol.21 (4), p.163-164

2014

Link zum Volltext

Verfügbarkeit prüfen

Is there still room for additional common susceptibility alleles for venous thromboembolism?

Journal of thrombosis and haemostasis, 2016-09, Vol.14 (9), p.1798-1802

2016

Link zum Volltext

Verfügbarkeit prüfen

Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders

Annals of the rheumatic diseases, 2009-01, Vol.68 (1), p.89-93

2009

Link zum Volltext

Verfügbarkeit prüfen

Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study

Journal of thrombosis and haemostasis, 2011-06, Vol.9 (6), p.1126-1132

2011

Link zum Volltext

Verfügbarkeit prüfen

Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

The New England journal of medicine, 2014-11, Vol.371 (19), p.1771-1780

2014

Link zum Volltext

Verfügbarkeit prüfen

Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2015-07, Vol.314 (1), p.31

2015

Link zum Volltext

Verfügbarkeit prüfen

Underweight is associated with a reduced risk of venous thromboembolism. Results from the EDITH case‐control study

Journal of thrombosis and haemostasis, 2009-04, Vol.7 (4), p.728-729

2009

Link zum Volltext

Verfügbarkeit prüfen

Multiple myeloma and venous thrombosis. Which thromboprophylaxis should be given?

La revue de medecine interne, 2016-07, Vol.37 (7), p.473-479

2016

Link zum Volltext

Verfügbarkeit prüfen

P-022 Risk of recurrence during pregnancy after a first VTE: A French cohort

Thrombosis research, 2013, Vol.131, p.S82-S82

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficient gene transfer in skeletal muscle with AAV-derived bicistronic vector using the FGF-1 IRES

Gene therapy, 2008-08, Vol.15 (15), p.1090-1098

2008

Link zum Volltext

Verfügbarkeit prüfen

Aspirin for secondary prevention of venous thromboembolism. WARFASA: far from being conclusive

La revue de medecine interne, 2013-02, Vol.34 (2), p.69-72

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 390

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(315)
Mit Volltextzugriff
(343)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(164)
Life Sciences & Biomedicine
(155)
Humans
(146)
Life Sciences
(107)
Female
(87)
Hematology
(76)
Middle Aged
(69)
Human Health And Pathology
(68)
Male
(68)
Cardiovascular System & Cardiology
(60)
Adult
(59)
Peripheral Vascular Disease
(57)
Aged
(53)
Venous Thromboembolism
(51)
Risk Factors
(48)
Aged, 80 And Over
(29)
Pulmonary Embolism
(29)
Cardiology And Cardiovascular System
(27)
Anticoagulants
(26)
Thrombosis
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of the ISTH

Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai‐VTE study

Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?

Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis

Oral contraception and menstrual bleeding during treatment of venous thromboembolism: Expert opinion versus current practice: Combined results of a systematic review, expert panel opinion and an international survey

What are the special features of treatment in the anti-phospho-lipid syndrome?

Net clinical benefit of hospitalization versus outpatient management of patients with acute pulmonary embolism

Antipsychotic drugs and the risk of recurrent venous thromboembolism: A prospective cohort study

Evaluating efficacy and safety of oral anticoagulation in adult patients with atrial fibrillation and cancer: A systemic review and meta-analysis

Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome

The risk of venous thromboembolism in renal cell carcinoma patients with residual tumor thrombus

Protein S Heerlen mutation heterozygosity is associated with venous thrombosis risk

Oral contraception and menstrual bleeding during treatment of venous thromboembolism: Expert opinion versus current practice

Venous thromboembolism in cancer patients: a call for more awareness

Is there still room for additional common susceptibility alleles for venous thromboembolism?

Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders

Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study

Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial

Underweight is associated with a reduced risk of venous thromboembolism. Results from the EDITH case‐control study

Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism: A Randomized Trial

Multiple myeloma and venous thrombosis. Which thromboprophylaxis should be given?

P-022 Risk of recurrence during pregnancy after a first VTE: A French cohort

Efficient gene transfer in skeletal muscle with AAV-derived bicistronic vector using the FGF-1 IRES

Aspirin for secondary prevention of venous thromboembolism. WARFASA: far from being conclusive

Suchergebnisse filtern